<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the results of unrelated cord blood transplantation (CBT) after myeloablative conditioning in 3 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>-<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RA) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were treated with total body irradiation, <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (Ara-C), and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, followed by unrelated HLA-mismatched CBT </plain></SENT>
<SENT sid="2" pm="."><plain>Granulocyte colony-stimulating factor was infused continuously, starting 12 hours before Ara-C therapy and continuing until the end of Ara-C therapy </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received standard <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> therapy as <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> prophylaxis </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had myeloid reconstitution, and the times to reach an absolute neutrophil count &gt;0.5 x 10(9)/L were 23, 20, and 26 days </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients showed full donor chimerism at the time of the first bone marrow examination (on day +42, +43, and +62) after CBT </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients are alive and free of disease at between 17 and 39 months after CBT </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that adult <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RA patients without suitable related or unrelated bone marrow donors should be considered as candidates for CBT </plain></SENT>
</text></document>